CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial

Shaun Cordoba, Shimobi Onuoha, Simon Thomas, +33

Nature Medicine

An APRIL-based chimeric antigen receptor for dual targeting of BCMA and TACI in multiple myeloma

Lydia Lee, Benjamin Draper, Neil Chaplin, +15

Blood

Efficient and reproducible generation of tumour-infiltrating lymphocytes for renal cell carcinoma

Vania Baldan, Richard W. Griffiths, Robert E. Hawkins, +1

British Journal of Cancer

Potential Limitations of the NSG Humanized Mouse as a Model System to Optimize Engineered Human T cell Therapy for Cancer

Erik Alcantar-Orozco, Hannah Gornall, Vania Baldan, +2

Human Gene Therapy Methods

Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants

Mathieu Ferrari, Leila Mekkaoui, F. Tudor Ilca, +17

Journal of Virology

Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR

Evangelia Kokalaki, Biao Ma, Mathieu Ferrari, +21

Molecular Therapy

Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies

Mathieu Ferrari, Matteo Righi, Vania Baldan, +33

Nature Communications